MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報，我們不為任何個人用途提供產(chǎn)品和服務(wù)。

N-Desmethylclozapine

產(chǎn)品活性：N-Desmethylclozapine 是非典型抗精神病有效劑 Clozapine 的主要活性代謝產(chǎn)物。N-Desmethylclozapine 是一種有效的、變構(gòu)的部分 M1 受體激動劑 (EC₅₀=115 nM)，能通過 M1 受體激活增強海馬 N-methyl-d-aspartate (NMDA) 受體電流。N-Desmethylclozapine 也是 δ-opioid 激動劑。

研究領(lǐng)域：GPCR/G Protein  |  Neuronal Signaling  |  Metabolic Enzyme/Protease  |  Anti-infection

作用靶點：mAChR  |  Opioid Receptor  |  Drug Metabolite  |  Virus Protease

In Vitro: The brain penetrant metabolite N-desmethylclozapine preferentially bound to M1 muscarinic receptors with an IC₅₀ of 55 nM and was a more potent partial agonist (EC₅₀, 115 nM and 50% of acetylcholine response) at this receptor than clozapine.
N-desmethylclozapine exhibits slight agonistic effects on the M1 mAChR, and agonistic properties at the 5-HT1A receptor in the cerebral cortex and hippocampus. This compound also behaves as an agonist at the δ-opioid receptor in the cerebral cortex and striatum.
N-desmethylclozapine (3 μM) greatly decreases the outward current in excitatory neurons, but not in inhibitory neurons. In excitatory neurons, N-desmethylclozapine alone is more effective than either clozapine alone or the combination of clozapine and N-desmethylclozapine. The effect of N-desmethylclozapine in excitatory neurons is significantly suppressed by 0.1 μM pirenzepine and 1 μM atropine. N-desmethylclozapine, but not clozapine, suppressed K⁺ channels via M1 receptors in excitatory cells.
N-desmethylclozapine leads to a decrease in TxB2 levels under unstimulated conditions as well as under TSST-1 stimulation. Clozapine, N-desmethylclozapine and CPZ possibly act on neurotransmitter systems via modulation of TxA2 or TxB2 production.
The IC₅₀s of N-desmethylclozapine, fluoxetine hydrochloride, and salmeterol xinafoate in Huh-7 cells infected with DENV-2 are 1 μM, 0.38 μM, and 0.67 μM, respectively. The levels of NS3 are reduced in cells treated with all three inhibitors compared to DMSO treatment, suggesting that the inhibitors act at a stage prior to viral protein translation. N-Desmethylclozapine-treated cells show a >75% reduction in negative-strand RNA levels.

In Vivo: N-desmethylclozapine in rat and human at M2 and M4 mAChRs underlying presynaptic modulation of GABA and glutamate release, respectively. In particular, N-desmethylclozapine maybe a M2 mAChR antagonist in the rat but has no activity at this receptor in human neocortex. However, N-desmethylclozapine has an agonistic effect at M4 mAChR in the human but no such effect in the rat neocortex.

相關(guān)產(chǎn)品：Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  GPCR/G Protein Compound Library  |  Metabolism/Protease Compound Library  |  Neuronal Signaling Compound Library  |  Clinical Compound Library  |  Antiviral Compound Library  |  Neurotransmitter Receptor Compound Library  |  Drug Metabolite Library  |  Antidepressant Compound Library  |  Human Metabolite Library  |  Pain-Related Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  VU0357017 hydrochloride  |  Nicotinamide N-oxide  |  Cirsiliol 4′-glucoside  |  Desglymidodrine  |  SRPIN340  |  Methyl-6-alpha-Naltrexol  |  [D-Ala2]-Met-Enkephalin  |  GSK1521498 free base  |  4-Methylamino antipyrine hydrochloride  |  Tazarotenic acid-d₆  |  5-Hydroxy tryptophol β-D-glucuronide-d₄  |  TBPB  |  Trospium EP impurity C-d₈ (chloride)  |  Melamine  |  Tropicamide-d₃  |  Imidafenacin  |  Febuxostat amide impurity  |  20-Carboxy-Leukotriene B4  |  Aminothiazole  |  O-Desmethyl Mebeverine acid-d₆  |  (-)-U-50488 hydrochloride  |  Desoxycarbadox  |  Ampyrone  |  SB-612111  |  Loxapine impurity 3-d₈ (iodide)  |  HMMNI-d₃  |  N-Desmethyl imatinib mesylate  |  (±)-Muscarine chloride  |  Cidofovir diphosphate tri(triethylamine)  |  SP inhibitor 1

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫，我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng)；
•   產(chǎn)品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產(chǎn)品，廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學(xué)分析檢測分析，藥物篩選等專業(yè)技術(shù)服務(wù)；
•   設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告，確保產(chǎn)品的高純度、高品質(zhì)；
•   產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業(yè)團(tuán)隊跟蹤新的制藥及生命科學(xué)研究進(jìn)展，為您提供*新的活性化合物；
•   與世界各大制藥公司及*科研機構(gòu)建立了長期的合作。